Jennifer L Welch1,2,3, Hussein Kaddour4, Lee Winchester5, Courtney V Fletcher5, Jack T Stapleton1,2,3, Chioma M Okeoma1,4. 1. Departments of Microbiology and Immunology. 2. Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA. 3. Medical Service, Iowa City Veterans Affairs Medical Center, Iowa City, IA. 4. Department of Pharmacology, Stony Brook University School of Medicine, Stony Brook, NY; and. 5. Antiviral Pharmacology Laboratory, College of Pharmacy, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, NE.
Abstract
BACKGROUND: Extracellular vesicles (EVs) are cell-derived vesicles with diverse functions in intercellular communication including disease and infection, and EVs seem to influence HIV-1 pathogenesis. EVs isolated from HIV-1-uninfected semen (SE), but not blood (BE), contain factors that interfere with HIV-1 infection and replication in target cells. The reason for this dichotomy is unknown. Furthermore, the effect of HIV-1 infection and antiretroviral (ARV) drugs on the anti-HIV-1 effects of SE and BE is unknown. Here, we characterize EVs and EV-free plasma isolated from HIV-infected donor semen and blood and their effects on HIV infection. METHODS: EVs and EV-free plasma were purified from autologous blood and semen of HIV-negative, HIV-infected antiretroviral therapy (ART)-naïve, and HIV-infected ART-treated participants. HIV infection was assessed in a TZM-bl cell reporter system. ARV concentrations were analyzed using liquid chromatography-mass spectrometry. RESULTS: SE isolated from both HIV-negative and HIV-infected, ART-naïve donors inhibited HIV-1 infection, but BE and semen and blood EV-free plasma did not. By contrast, BE, SE, and EV-free plasma from HIV-infected, ART-treated donors inhibited HIV-1. Importantly, exosomes isolated from ART-treated donors contained concentrations of ARV drugs (ART-EVs) at biologically relevant inhibitory levels. CONCLUSIONS: The HIV-1-inhibitory phenotype of SE is independent of donor HIV-1 or ART status, and ARV drugs and their metabolites are SE- and BE-associated in vivo.
BACKGROUND: Extracellular vesicles (EVs) are cell-derived vesicles with diverse functions in intercellular communication including disease and infection, and EVs seem to influence HIV-1 pathogenesis. EVs isolated from HIV-1-uninfected semen (SE), but not blood (BE), contain factors that interfere with HIV-1 infection and replication in target cells. The reason for this dichotomy is unknown. Furthermore, the effect of HIV-1 infection and antiretroviral (ARV) drugs on the anti-HIV-1 effects of SE and BE is unknown. Here, we characterize EVs and EV-free plasma isolated from HIV-infected donor semen and blood and their effects on HIV infection. METHODS: EVs and EV-free plasma were purified from autologous blood and semen of HIV-negative, HIV-infected antiretroviral therapy (ART)-naïve, and HIV-infected ART-treated participants. HIV infection was assessed in a TZM-bl cell reporter system. ARV concentrations were analyzed using liquid chromatography-mass spectrometry. RESULTS: SE isolated from both HIV-negative and HIV-infected, ART-naïve donors inhibited HIV-1 infection, but BE and semen and blood EV-free plasma did not. By contrast, BE, SE, and EV-free plasma from HIV-infected, ART-treated donors inhibited HIV-1. Importantly, exosomes isolated from ART-treated donors contained concentrations of ARV drugs (ART-EVs) at biologically relevant inhibitory levels. CONCLUSIONS: The HIV-1-inhibitory phenotype of SE is independent of donor HIV-1 or ART status, and ARV drugs and their metabolites are SE- and BE-associated in vivo.
Authors: Jennifer L Welch; Hussein Kaddour; Patrick M Schlievert; Jack T Stapleton; Chioma M Okeoma Journal: J Virol Date: 2018-10-12 Impact factor: 5.103
Authors: Jan Münch; Elke Rücker; Ludger Ständker; Knut Adermann; Christine Goffinet; Michael Schindler; Steffen Wildum; Raghavan Chinnadurai; Devi Rajan; Anke Specht; Guillermo Giménez-Gallego; Pedro Cuevas Sánchez; Douglas M Fowler; Atanas Koulov; Jeffery W Kelly; Walther Mothes; Jean-Charles Grivel; Leonid Margolis; Oliver T Keppler; Wolf-Georg Forssmann; Frank Kirchhoff Journal: Cell Date: 2007-12-14 Impact factor: 41.582
Authors: Hussein Kaddour; Steven Kopcho; Yuan Lyu; Nadia Shouman; Victor Paromov; Siddharth Pratap; Chandravanu Dash; Eun-Young Kim; Jeremy Martinson; Heather McKay; Marta Epeldegui; Joseph B Margolick; Jack T Stapleton; Chioma M Okeoma Journal: Cell Mol Life Sci Date: 2021-12-22 Impact factor: 9.207
Authors: Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha Journal: Mol Neurobiol Date: 2021-06-26 Impact factor: 5.590
Authors: A S Vickram; P S Srikumar; S Srinivasan; Palanivelu Jeyanthi; K Anbarasu; S Thanigaivel; Dey Nibedita; D Jenila Rani; Karunakaran Rohini Journal: Saudi J Biol Sci Date: 2021-03-17 Impact factor: 4.219
Authors: Hussein Kaddour; Tyler D Panzner; Jennifer L Welch; Nadia Shouman; Mahesh Mohan; Jack T Stapleton; Chioma M Okeoma Journal: Viruses Date: 2020-10-01 Impact factor: 5.048
Authors: Hussein Kaddour; Yuan Lyu; Jennifer L Welch; Victor Paromov; Sammed N Mandape; Shruti S Sakhare; Jui Pandhare; Jack T Stapleton; Siddharth Pratap; Chandravanu Dash; Chioma M Okeoma Journal: Mol Cell Proteomics Date: 2019-11-01 Impact factor: 7.381